ZYBERNO
Stock Report
Updated Sep 1, 2026

VYOME HOLDINGS, INC. (HIND)

Healthcare • NASDAQ

$2.15

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
16.0/100
POOR BUSINESS
VYOME HOLDINGS, INC. (HIND) scores 16/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-186.8%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.01x)
Operating Margin (Operational Efficiency):CRITICAL (-3,290.1%)
Return on Capital (Capital Efficiency):CRITICAL (-724.2%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

VYOME HOLDINGS, INC. (HIND) stock report — Zyberno Score 16/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.15
Market Cap:$15.09M

Valuation Multiples (3)

P/B Ratio:2.06x
P/S Ratio:39.89x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$7.26M

Price Action & Momentum (3)

Momentum Percentile:2 / 100
% of 52-Week High:22.2%
B. Profitability Assessment

Return Metrics (5)

ROA:-130.7%
Reinvestment Rate:0.1%
Fundamental Growth Rate (g):-0.9%

Margin Analysis (3)

Operating Margin Ttm:-3,290.1%
Net Margin Ttm:-2,843.1%
Ebitda Margin:-3,286.9%

TTM Performance (3)

Gross Margin Ttm:65.3%
Operating Margin Ttm:-3,290.1%
Net Margin Ttm:-2,843.1%

Yield Metrics (2)

Earnings Yield:-$1.00K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-103.2%
Latest Earnings Filed:2026-08-12

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-50.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:4.37x
Quick Ratio:3.00x
Cash Ratio:4.23x

Leverage Analysis (3)

Debt To Equity Ttm:0.01x
Debt-to-Equity Ratio:0.01x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-3,143.63x
Times Interest Earned:-3,143.63

Capital Structure (4)

Working Capital:6,288,697.00
Cash And Cash Equivalents:7,887,510.00
Long Term Debt:$31.26K
Net Debt:-$7.82M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $378.26K
Linear Growth: -50.0%
📊 Click to view full HIND Revenue analysis & methodology →
Cost Of Revenue Ttm:$131.19K

Profitability Breakdown (2)

Gross profit TTM: $247.07K
Linear Growth: -50.0%
📊 Click to view full HIND Gross Profit analysis & methodology →
-$12.45M

Bottom Line Performance (3)

-$10.75M
Income Before Tax:-$4.47M
Ebitda Ttm:-12,433,091.00

Operating Expenses (5)

Operating Expenses:12,692,150.00
R And D Expense:1,761,386.00
Sga Expense:3,208,031.00
Income Tax Expense:$25.00K
Interest Expense:3,325.00

Expense Ratios (3)

R And D To Revenue Percentage:6,534.5%
Sga To Revenue Percentage:11,901.4%
Ebitda Margin:-3,286.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$9.18M
Current Assets:$8.15M
Ppe Net:544,867.00
Goodwill:0.00
Intangible Assets:$314.19K

Liability Structure (4)

Total Liabilities:1,864,656.00
Current Liabilities:1,864,656.00
Long Term Debt:$31.26K
Short Term Debt:$31.26K

Equity & Capital (3)

Equity:$7.31M
Retained Earnings:-$89.21M
Common Stock:300,000,000.00

Working Capital Items (3)

Accounts Receivable:2,181.00
Inventory:2,552,000.00
Accounts Payable:546,699.00

Special Items (2)

Contract Liabilities:40,105.00
Stock Based Compensation:5,696.00
C. Cash Flow Analysis

Operating Activities (2)

-$3.07M$0.00

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$5.29M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:5,288,868.00
Long Term Debt Issuance:$600.00K
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-21.84
-$21.84
Earnings Per Share Ttm:-$1.53

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.05
Operating Cash Flow Per Share:-$0.53

Book Value & Capital (2)

Book Value Per Share:$1.04
Cash Per Share:1.12

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.05x
Working Capital Turnover Ttm:0.06x

Receivables Management (2)

Receivables Turnover Ttm:173.43x
Days Sales Outstanding Ttm:2.10

Inventory Management (2)

Inventory Turnover Ttm:0.05x
Days Inventory Outstanding Ttm:7,100.45

Payables & Cash Cycle (2)

Days Payable Outstanding:1,521.09
Cash Conversion Cycle:5,581.47
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:0.1%
Fundamental Growth Rate (g):-0.9%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-50.0%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-50.0%
Book Value Growth Rate (Linear):-27.2%
C. Company Profile & Context

Corporate Information (6)

Symbol:HIND
Company Name:VYOME HOLDINGS, INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:7.02M
Shares Outstanding Basic:7.02M
Shares Outstanding Diluted:6.69M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 14:02:02 UTC
Data Timestamp:2026-08-21T10:35:19.475496
Scroll to Top